12 July 2022: Database Analysis
LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer
Aimin Chang ACDEFG* , Ying Shi BCDE , Ping Wang BCD , Jingjing Ren BCFDOI: 10.12659/MSM.935070
Med Sci Monit 2022; 28:e935070
Table 3 (A) Overall survival and clinicopathologic characteristics in patients from The Cancer Genome Atlas database evaluated using Cox regression. (B) Multivariate survival model after variable selection.
| Characteristics | HR (95% CI) nnivariate analysis | P value nnivariate analysis |
|---|---|---|
| T stage (T2&T3&T4 vs T1) | 1.846 (1.045–3.260) | 0.035 |
| N stage (N1 vs N0) | 2.695 (1.358–5.349) | 0.005 |
| Clinical stage (Stage II & Stage III & Stage IV vs Stage I) | 1.429 (0.896–2.280) | 0.134 |
| Primary therapy outcome (CR vs PD&SD&PR) | 0.074 (0.040–0.138) | |
| Age (>50 vs ≤50) | 1.317 (0.825–2.101) | 0.248 |
| Height (>160 vs ≤160) | 1.092 (0.633–1.883) | 0.752 |
| Weight (>70 vs ≤70) | 0.736 (0.446–1.214) | 0.230 |
| LINC00963 (high vs low) | 0.557 (0.347–0.894) | 0.015 |
| N stage (N1 vs N0) | 3.878 (1.493–10.071) | 0.005 |
| Primary therapy outcome (CR vs PD&SD&PR) | 0.162 (0.059–0.446) | |
| LINC00963 (high vs low) | 0.297 (0.115–0.766) | 0.012 |